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Edited by Lukas HuberAbstract RELMb (resistin-like molecule) represents the most
related human homologue of mouse RELMa, also known as hyp-
oxic-induced mitogenic factor (HIMF). In this study, we isolated
RELMb cDNA from human lung tissue and performed regulatory
and functional expression studies. RELMb mRNA was upregu-
lated in hypoxia in human lung A549 cell line as well as primary
cultured adventitial ﬁbroblasts and smooth muscle cells (SMC)
of pulmonary arteries. Upon transfection of a RELMb encoding
expression plasmid into these cells, we observed signiﬁcant induc-
tion of proliferation particularly in SMC and A549 cells, which
could be blocked by phosphatidyl-inositol 3-kinase (PI3K) inhibi-
tors LY294002 and wortmannin. The results suggest that human
RELMb may contribute to hypoxic-induced pulmonary vascular
remodeling processes or hypoxia related ﬁbrotic lung disease.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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RELMb (resistin-like molecule) and resistin are the two hu-
man members of the resistin gene family also named FIZZ2
and FIZZ3 (found in inﬂammatory zone) encoding small cys-
teine-rich secreted proteins [1,2]. In mouse, a third member
RELMa (FIZZ1) has been identiﬁed not present in human
[3,4]. Mouse RELMa is also described as hypoxia-inducible
mitogenic factor (HIMF) and strongly contributes to hyp-
oxic-induced pulmonary vascular remodeling by triggering
proliferation of smooth muscle cells (SMC) and exerting
strong vasoconstrictive eﬀects on pulmonary vasculature.
Additionally, angiogenic properties have been described for
HIMF [3]. Since RELMb is the closest human homologue of
mouse HIMF, we were interested in RELMb gene expression
especially in human lung. We isolated its cDNA from human
lung homogenate, and studied its hypoxic dependent regula-
tion in pulmonary vascular cells and human lung epithelial
A549 cell line. We observed signiﬁcant induction of RELMb
in hypoxia and found proliferative eﬀects particularly inAbbreviations: RELM, resistin like molecule; HIMF, hypoxic-induced
mitogenic factor; FIZZ, protein found in inﬂammatory zone; SMC,
smooth muscle cells; FB, ﬁbroblast
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liferation appeared to be mediated by phosphatidyl-inositol-ki-
nase (PI3K) pathway, since LY294002 and wortmannin
inhibited proliferation strongly in RELMb transfected cells.2. Materials and methods
2.1. Cell culture and human lung tissue
Culturing of human epithelial lung cell line A549 was performed
according to the protocol given by the American type culture collec-
tion. Human cell preparations were established from excess lung tissue
originating from human donor lungs employed for transplantation.
This protocol was approved by the Justus-Liebig University Ethics
committee. Cells were isolated by careful dissection of parenchymal
connective tissue as described. Primary adventitial ﬁbroblasts (FB)
and SMC from the pulmonary artery were isolated and cultured as de-
scribed [5]. In brief, primary FB were isolated from human pulmonary
artery by careful dissection of parenchymal connective tissue. The
adventitia of <1 mm3 tissue pieces was removed and placed into 12-
well cell culture plates with 500 ll culture medium. Primary SMC were
isolated from human pulmonary artery by carefully preparing <1 mm3
pieces of media, devoid of adventitial tissue as assessed by microscopic
control. Experiments were performed with cells in passage 3 or 4.2.2. Transfection
For transfection, cells were grown to 80% conﬂuence. 0.2 lg
Plasmid-DNA was mixed with synthetic peptide Tat-RGD (GML
GIS YGR KKR RQR RRP PQT GGC RGD MFG C) which was
employed as an enhancer of transfection. 2.5 lg of Tat-RGD was
used per well for A549 cells and 0.8 lg/well for FB and SMC. The
volume was made up to 25 ll with Hank’s buﬀered saline. This mix-
ture was incubated at room temperature for 15 min. Then 0.5 ll/well
Lipofectamin 2000 (Invitrogen, Carlsbad, CA, USA) was added and
incubated at room temperature for further 15 min. This mixture was
added to the cells. Followed by incubation at 37 C for 4 h, the med-
ium was replaced and cells cultured under standard conditions for
24 h.2.3. Isolation and construction of expression plasmid for RELMb cDNA
For cloning of the full length RELMb cDNA we performed RT-
PCR using RNA extracts from human lung tissue with primers derived
from human RELMb cDNA sequence (Accession No.: AF323084):
PHIMF-f: ccc cag gac act gac tct gta and M-HIMF-f: aaa ctg agt tct
cag cct cct c. The puriﬁed PCR product was ligated into pGEM-T-easy
plasmid (Promega) and positive clones were sequenced. Inserts from
pGEM-T-easy plasmid were ampliﬁed by PCR for subcloning into
pCMV expression plasmid (Clontech, Paolo Alto, USA) using the fol-
lowing primers: HIMF-kozak-kpn1: ctt ggt acc gcc gcc acc ATG GGG
CCG TCC TCT TGC CTC C; HIMF-HA-TGA-xho1: gaa ctc gag tca
gcc gcc acc agc gta atc tgg aac atc gta tgg gta gcc acc ggt cag gtg gca
gca gcg ggc agt ggt cc. The forward primer contained a Kozak sequence
as an optimized translation start and the reverse primer carried a hem-
eagglutinin A (HA) tag in frame at the C-terminus.blished by Elsevier B.V. All rights reserved.
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RNA was extracted from human lung tissue or cells incubated for
24 h in normoxic or hypoxic (1% oxygen concentration) conditions
using guanidine thiocyanate-acid phenol (RNAzol B, WAK-Chemie,
Germany). Total RNA for human tissues screening were purchased
(Premium RNA; Clontech, Paolo Alto, USA). 1 lg of RNA per sam-
ple was copied to cDNA using reverse transcriptase (MMLV-RT,
Invitrogen, Carlsbad, CA, USA) with 100 ng 15-mers of oligo-dT pri-
mer. As a negative control, MMLV-RT was omitted (data not shown).
The following primers were used: hRELMb+: 5 0 CCC TTC TCC AGC
TGA TCA AC 3 0, hRELMb: 5 0 CCA CGA ACC ACA GCC ATA
G 3 0, HPRT+: 5 0 TCG AGA TGT GAT GAA GGAGAT GGG A 3 0,
HPRT: 5 0 TCA AAT CCA ACA AAG TCT GGC CTG T 3 0. The
cycling conditions were 95 C for 15 m, followed by 40 cycles of
94 C for 10 s, 52 C for 30 s, 72 C for 30 s and a ﬁnal extension with
72 C for 10 m. Real-time PCR was performed using the ABI Prism
7700 detection system (Applied Biosystems, Foster City, CA, USA)
with SYBR-Green as ﬂuorescent dye, enabling real-time detection of
PCR products according to the manufacturer’s protocol. HPRT
mRNA was used as internal control for calculation of DCT (Threshold
cycle) values and relative quantiﬁcation.
2.5. Western-blot
Cells were lysed using Laemmli buﬀer and denatured for 5 m at
95 C and run on a sodium dodecyl sulfate–polyacrylamide gel. After
electroblot of the gel to a nylon membrane (PVDF, Pal), HA speciﬁc
bands were visualized by a monoclonal mouse antibody against HA
added at a dilution of 1:10000 (Sigma–Aldrich) and chemilumines-
cence (ECL, Amersham, Freiburg, Germany) by using a second bio-
tin-coupled anti-mouse antibody and a complex of biotin and
streptavidin coupled with horseradish peroxidase. As a loading con-
trol, samples were also analyzed by Western-blot analysis for cytoplas-
mic b-actin with a mouse monoclonal anti b-actin antibody (Abcam,
1:10000 dilution).
2.6. MTT assay
The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide) assay was performed as a measurement of number of viable cells.
Cells were seeded in 96-wellplates and transfected by expression plas-
mid. After 24 h, MTT (0.2 mg/ml) was added to each well, and incuba-
tion continued for 1–2 h at 37 C. The extent ofMTT reduction to
formazan within cells was quantiﬁed by spectrophotometric measure-
ment at 490 nm.
2.7. BrdU incorporation
Cellular DNA synthesis (cell cycle S-phase) was assessed by incorpo-
ration of the thymidine analogue 5-bromo-20-deoxyuridine (BrdU)
into the DNA of replicating cells using a commercially available color-
imetric immunoassay according to the recommended protocol of the
company (Roche, Mannheim, Germany). After addition of BrdU to
cells they were ﬁxed and incorporated BrdU was measured by ELISA
using a speciﬁc BrdU antibody. The values given in the ﬁgures repre-
sent the raw data obtained by photometric measurement at 450 nm.Fig. 1. (A) RELMb mRNA expression as analyzed by RT-PCR in
various human tissues (L: liver; H: heart; Lu: Lung; K: kidney; B:
brain; C: colon intestine; Ad: adrenal gland). As a control, house
keeping RT-PCR product of HPRT mRNA is shown. (B) Quantiﬁ-
cation of RELMb mRNA in A549 cells, SMC and FB cultured in
normoxia (N) or hypoxia (H) for 24 h by real-time RT-PCR in
comparison to HPRT mRNA (mean ± S.E.M., n = 3). A representa-
tive gel electrophoretic analysis of the integrity and speciﬁcity of the
PCR products from the realtime RT-PCRs is shown below the bar
graph.3. Results
For analysis of human RELMb gene expression, we initially
isolated a full-length cDNA of RELMb from human lung tis-
sue RNA by RT-PCR strategy. The nucleic acid sequence (Sub-
mitted to EMBL Accession No.: AM050721) diﬀered at
positions 59 and 97 after start of translation from a published
sequence (Accession No.: AF323084), resulting in two amino-
acid exchanges (proline to leucine and lysine to glutamine).
The alignment of cDNAs of human RELMb and mouse HIMF
(NCBI Accession No.: BC029248) reveals sequence identity of
69%. Comparison of the amino acid sequences yields a se-
quence similarity of 58.6% and a sequence identity of 49.6%.
Tissue screening of RELMb expression revealed expression
in lung, heart, kidney and adrenal gland, highest expressionin intestine, whereas in brain and liver no signal was detectable
(Fig. 1A). Since HIMF plays an important role in hypoxic
adaptive processes in lung physiology in mouse, we analyzed
hypoxic gene regulation of RELMb, a HIMF homologue, in
human lung cells. To this end, we employed the lung epithelial
A549 cell line, as well as primary cultured SMC and adventitial
FB from human pulmonary arteries (Fig. 1B). RELMb
mRNA was analyzed in extracts of these cells by realtime-
RT-PCR. When related to the house keeping gene hypoxan-
thin-phospho-ribosyl-transferase (HPRT) mRNA, we found
highest basal RELMb mRNA levels in SMC followed by
A549 and FB cells. Strongest RELMb mRNA hypoxic induc-
tion was observed in A549 cells followed by SMC and FB. For
further functional analysis, we transfected these cells by an
expression plasmid recombinant with RELMb cDNA and
tagged with hemeaglutinin A (HA) for protein analysis by
anti-HA antibody. Control cells were transfected with the cor-
responding empty plasmid. Transfected cells were studied with
regard to proliferation by measuring the overall cellular mito-
chondrial respiratory chain activity with MTT assay and cellu-
lar DNA synthesis by BrdU incorpration (Fig. 2A and B).
Induction of proliferation by RELMb was observed in all
investigated cell types, being stronger in A549 and SMC than
Fig. 3. Analysis of proliferation as measured by BrdU incorporation
in A549 cells. Cells were either non-transfected (cells) or transfected by
pCMV-HA, or by pCMV-RELMb-HA and then incubated with
LY29004 (40 lM) or wortmannin (100 nM) added to the medium
(mean ± S.D., n = 5, ** < 0.01 Mann–Whitney-test).
Fig. 2. Analysis of proliferation by MTT test or BrdU incorporation
of A549 cells, SMC and FB cells transfected with RELMb-HA tagged
expression plasmid (pCMV-RELMb-HA) or empty plasmid (pCMV).
Signiﬁcant induction of proliferation in cells overexpressing hRELMb
is observed. (A) MTT results (mean ± S.D., n = 4 * < 0.05 Mann–
Whitney-test). (B) BrdU results (mean ± S.D., n = 8 for A549, n = 6
for FB, n = 8 for SMC, * < 0.05, ** < 0.01 Mann–Whitney-test). (C)
As a control for RELMb overexpression, cellular extracts were
analyzed by HA-Western-blot showing signals only in case of
pCMV-RELMb-HA transfected cells (R) but not in empty plasmid
transfected cells (pCMV). Shown is a representative blot of n > 3
experiments.
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cDNA was conﬁrmed by HA Western-blot analysis (Fig. 2C)
showing immunoreactivity in RELMb transfected cells but
not in empty plasmid transfected cells. Since the mitogenic ef-
fect of HIMF in mouse cells could be blocked by inhibitors of
PI3K/Akt signal transduction, we performed experiments
employing wortmannin or LY294002 for inhibition of PI3K.
In A549 cells which were transfected by RELMb expression
plasmid, we observed signiﬁcant reduction of proliferation
(>50%) when treated with wortmannin or LY294002. In cells
transfected with empty vector, we observed no eﬀect on prolif-
eration using these inhibitors. As a further control, we in-
cluded non-transfected cells in the experiments. These cells
revealed higher S-phase activity when compared to the trans-
fected cells and demonstrated a signiﬁcant but slight decrease
(15%) of proliferation upon PI3K inhibitor treatments
(Fig. 3).4. Discussion
In this study, we have analyzed the gene expression, hyp-
oxic regulation and proliferative eﬀects of RELMb in human
lung cells. Our study was inspired by investigations on the
related HIMF gene in mouse, also described in other context
as RELMa or FIZZ1 [3]. Human RELMb represents the
gene with the highest homology with mouse HIMF, how-
ever, it is not considered as the human ortholog gene of
mouse HIMF, which appears not to exist [4]. In this report,
we have analyzed the expression, hypoxic regulation and
pro-proliferative potency of RELMb on human lung cells.
We analyzed the expression pattern of human RELMb on
mRNA level by RT-PCR in several human tissues and
found highest expression in lung, heart, colon, and adrenal
gland, followed by kidney. Two studies examined HIMF
expression in mouse. At protein level HIMF was only
detectable by Western-blot in lung from hypoxic treated
mice [3]. At mRNA level as analyzed by Northern-blot [6],
HIMF was abundantly expressed in lung and less but signif-
icantly expressed in heart and skeletal muscle, whereas no
signal was observed in brain and liver in accordance with
our study. In conclusion, so far described diﬀerences and
common grounds exist for expression of RELMb in human,
and of HIMF in mouse.
We found hypoxic induction of RELMb in A549 cell line
and primary vascular cells from human pulmonary arteries.
The hypoxic induction was strongest in A549 cells followed
by SMC and FB. Probably, this observation reﬂects that the
expression of a given gene is regulated by speciﬁc factors which
diﬀer between cells. Hypoxic gene induction may be HIF-
dependent via hypoxia-responsive-elements (HRE) [7]. Bioin-
formatic analysis of the human RELMb gene revealed ﬁve
putative HRE (RCGTG) binding sites. One site was located
in the intervening intron sequence 2, and four at the 3 0 ﬂanking
region (Table 1A). These putative regulatory DNA sequences
need further experimental proof for their functional relevance.
As comparison, putative HREs of the corresponding mouse
HIMF gene are shown (Table 1B). Two HRE sites in the 5 0
ﬂanking region were detected which also require experimental
investigation.
Table 1A
Putative HRE sequences of human RELMb gene (EMBL Accession
No.: AF352731)
HRE sequence Location
gacgt ACGTG cagggaga IVS2 4033/4016
cacta ACGTG gcatctag 3 0FS +314/+331
tgtcc ACGTG atctcatt 3 0FS +417/+434
aacat ACGTG tgcatgtg 3 0FS +674/+691
catag GCGTG ggcaagga 3 0FS +1303/+1286
Table 1B
Putative HRE sequences of mouse RELMa (HIMF) gene (EMBL
Accession No.: mm_ensembl11:CHR16_11_1177_04)
HRE sequence Location
tacag ACGTG gatgctct 5 0FS 3805/3788
tgtgt GCGTG tgtgtgtg 5 0FS 624/610
HRE core sequence: RCGTG (R is A or G), IVS: Intervening sequence
(intron), FS: ﬂanking sequence (numbering: 3 0FS: + is downstream
from end of transcription; 5 0FS:  is upstream from start of tran-
scription; IVS2: numbering with regard to complete gene sequence).
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liferative eﬀects were observed. Thus, this study suggests that
RELMb in the human system is similarly regulated as de-
scribed for HIMF in mouse, and acts as a hypoxia-driven
pro-proliferative factor. Moreover, the pro-proliferative eﬀect
of RELMb could be suppressed by two PI3K inhibitors, a
characteristic also observed for HIMF in mouse cells. PI3K
has been demonstrated to mediate proliferation in human pul-
monary SMC via serine/threonine kinase Akt which directly
aﬀects cell cycle regulation [8]. Thus, the signalling mechanisms
by so far unknown receptors appear to be similar between
RELMb and HIMF. Consequently, RELMb in human may
play a role in hypoxic-induced pulmonary remodelling leading
to pulmonary hypertension, and in ﬁbrotic lung diseases asso-
ciated with hypoxia.
Further features of HIMF were explored in mice experi-
ments. Beside proliferative eﬀects, HIMF was demonstrated
to have angiogenic (subcutaneous mouse in vivo matrigel plug
model) and vasoconstrictive properties in pulmonary artery
[3]. In addition, HIMF was shown to play a role in lung devel-
opment, by regulation of apoptosis and participation in alveo-
larization and lung maturation [9] and compensatory lung
growth after pneumectomy [10]. Also, HIMF (FIZZ1) was
shown to be strongly increased during allergic pulmonary
inﬂammation [6]. The exploration of these characteristics
regarding RELMb in the human system remains open. So
far, functional aspects of RELMb and resistin have been
mainly described in mice with respect to resistence to insulin
[2,11,12]. Resistin, mainly expressed in adipocytes, andRELMb, expressed particularly expressed in epithelial cells
from intestine, were demonstrated to mediate resistance to
insulin leading to increased glucose production.
In sum, our study revealed new ﬁndings for human RELMb
as a factor which is induced in hypoxia and which exerts pro-
proliferative eﬀects. These eﬀects were observed in human pri-
mary vascular cells originating from pulmonary arteries, and
in lung A549 cell line. Thus, features of human lung RELMb
resemble those of HIMF in mouse lungs.Acknowledgments: This work was supported by the Deutsche Fors-
chungsgemeinschaft: Sonderforschungs-bereich SFB 547, project B9,
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